Skip to main content
Premium Trial:

Request an Annual Quote

Paired Ends: Sep 28, 2010

Premium

Pacific Biosciences has appointed David Baltimore to its board of directors, the company disclosed in a filing with the Securities and Exchange Commission this month.

Since 2006, Baltimore has been the president emeritus and the Robert Andrews Millikan Professor of Biology at the California Institute of Technology, and was the president of Caltech from 1997 to 2006. Before that, he was a professor at the Massachusetts Institute of Technology and Rockefeller University, where he also served as president. He was co-recipient of the Nobel Prize in medicine in 1975, and received the National Medal of Science in 1999.

Baltimore holds a BA in chemistry from Swarthmore College, a PhD from Rockefeller University, and was a postdoctoral fellow at MIT and the Albert Einstein College of Medicine.



Helicos BioSciences
has appointed Ivan Trifunovich as executive chairman of its board of directors, replacing Stanley Lapidus, who stepped down from the position of executive chairman but will continue to serve on the board.

Trifunovich has been providing consulting services to Helicos since August, earning $45,000. As executive chairman he will earn $30,000 per month. From 2001 to 2008, Trifunovich served as senior vice president for molecular diagnostics firm Third Wave Technologies. He has also held management positions at Pharmacia and Johnson & Johnson.

He holds a PhD in organic chemistry from the University of California, Los Angeles, and an MBA from the University of Pennsylvania's Wharton School of Business.


Metamark Genetics has named Gregory Critchfield to its board of directors. Critchfield served as president and board member of Myriad Genetic Laboratories until March, when he retired. At Myriad, he was responsible for building the company's scientific, medical, and commercial capabilities and launching seven molecular diagnostic products across a variety of technology platforms. He was also recently named to the board of Saladax Biomedical, a diagnostic test developer.



Carlos Bustamante
has been named a 2010 MacArthur Fellow. Bustamante is a professor of genetics and population biologist at Stanford University School of Medicine. He uses sequence data to study human migration, evolution, and natural selection. He holds his BA and PhD from Harvard University, and was a postdoctoral fellow at the University of Oxford.
The Scan

Genetic Risk Factors for Hypertension Can Help Identify Those at Risk for Cardiovascular Disease

Genetically predicted high blood pressure risk is also associated with increased cardiovascular disease risk, a new JAMA Cardiology study says.

Circulating Tumor DNA Linked to Post-Treatment Relapse in Breast Cancer

Post-treatment detection of circulating tumor DNA may identify breast cancer patients who are more likely to relapse, a new JCO Precision Oncology study finds.

Genetics Influence Level of Depression Tied to Trauma Exposure, Study Finds

Researchers examine the interplay of trauma, genetics, and major depressive disorder in JAMA Psychiatry.

UCLA Team Reports Cost-Effective Liquid Biopsy Approach for Cancer Detection

The researchers report in Nature Communications that their liquid biopsy approach has high specificity in detecting all- and early-stage cancers.